Literature DB >> 9407352

Hepatocellular carcinoma: clinicopathological aspects.

K Okuda1.   

Abstract

The histopathology and clinical picture of hepatocellular carcinoma (HCC) varies between individual patients and regions. These variations are perhaps due to differences in the genetic alterations that precede hepatocarcinogenesis. In this study, the clinicopathological features of HCC were compared between southern African blacks and Japanese, indicating large differences in the frequency of underlying cirrhosis, grade of cancer cell differentiation and clinical course. Intra-abdominal bleeding and febrile, rapidly progressive HCC are more common among blacks. Such a difference is accounted for, in part, by frequent encapsulation of the tumour which is well differentiated, and grows slowly in an expanding fashion in Japan. Encapsulated HCC was not seen among the black patients studied. Other distinct clinicopathological types discussed in this paper include diffuse-type HCC which is usually caused by multiple portal spread occurring almost simultaneously; the clinical course is fulminant. Sclerosing carcinoma is frequently associated with hypercalcaemia in the United States, but not in Japan. Fibrolamellar carcinoma is nearly non-existent in Asia, whereas it is common among young adults in the West. Its prognosis is generally better than ordinary HCC. Hepatocellular carcinoma has a strong propensity to invade vessel and duct systems. Portal invasion does not produce distinct clinical signs although it may aggravate portal hypertension. Patients with tumour occlusion in the major portal vein may give rise to ischaemic hepatitis when blood pressure drops suddenly in the preterminal stage. Liver parenchyma develops submassive necrosis and clinically there is an acute rise in alanine aminotransferase (ALT). Invasion into a major hepatic vein and the inferior vena cava also occurs, but less frequently compared with portal invasion. The patient can live even with a tumour thrombus in the atrium crossing the tricuspid valves. Intraductal invasion causes acute jaundice as well as an occasional haemobilia with pain. We recently found that a distinct pathological type called 'extrahepatic growth' or 'pedunculated HCC' develops as a result of fusion of right-sided adrenal metastasis of HCC and the liver, perhaps through the 'adreno-hepatic fusion' which is rather common in cirrhotic livers.

Entities:  

Mesh:

Year:  1997        PMID: 9407352     DOI: 10.1111/j.1440-1746.1997.tb00515.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  24 in total

Review 1.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

2.  Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma.

Authors:  Lian-Yue Yang; Wei Wang; Ji-Xiang Peng; Jie-Quan Yang; Gen-Wen Huang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

3.  Right Atrium Invasion of Tumor Thrombus from Hepatocellular Carcinoma Incidentally Found on Transthoracic Echocardiogram.

Authors:  Tomoki Sempokuya; Dennis T Bolger
Journal:  Hawaii J Med Public Health       Date:  2018-06

4.  Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging.

Authors:  Nobuhiro Fujita; Akihiro Nishie; Yuichiro Kubo; Yoshiki Asayama; Yasuhiro Ushijima; Yukihisa Takayama; Koichiro Moirta; Ken Shirabe; Shinichi Aishima; Hiroshi Honda
Journal:  Eur Radiol       Date:  2014-07-26       Impact factor: 5.315

5.  Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging.

Authors:  Weihua Guo; Suhong Zhao; Yuhai Yang; Guangrui Shao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 6.  Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Tiffany Hennedige; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  From the liver to the foot: a case of systemic embolism and acrometastasis in hepatocellular carcinoma.

Authors:  Ghaith Abu-Zeinah; Dwight Owen; Carlos Prieto-Granada; Natasha Rekhtman; David Klimstra; Dipti Gupta; James Harding; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2014-05

Review 8.  Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.

Authors:  Kazuhiko Sakamoto; Hiroaki Nagano
Journal:  Surg Today       Date:  2017-12-26       Impact factor: 2.549

9.  CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.

Authors:  Akihiro Nishie; Kengo Yoshimitsu; Daisuke Okamoto; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Ken Shirabe; Nobuhiro Fujita; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2012-10-17       Impact factor: 2.374

10.  Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Authors:  Jing-jing Zhao; Ke Pan; Jian-jun Li; Yi-bing Chen; Ju-gao Chen; Lin Lv; Dan-dan Wang; Qiu-zhong Pan; Min-shan Chen; Jian-chuan Xia
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.